Related Experiment Videos

Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database

Mellissa Yong1, Wilma Marieke Schoonen, Lin Li

  • 1Global Epidemiology, Amgen, Inc., Thousand Oaks, CA 91320, USA. myong@amgen.com

British Journal of Haematology
|April 10, 2010
PubMed

Insights

This study found immune thrombocytopenia (ITP) incidence in children is 4.2 per 100,000 person-years, with higher rates in young boys. ITP is rarely fatal in pediatric patients, but its causes remain largely unknown.

Area of Science:

  • Pediatric Hematology
  • Epidemiology
  • Immunology

Background:

  • Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder.
  • Understanding ITP incidence and risk factors in children is crucial for public health.
  • Previous studies have not fully elucidated ITP's epidemiological characteristics in pediatric populations.

Purpose of the Study:

  • To determine the incidence of immune thrombocytopenia (ITP) in pediatric patients.
  • To identify demographic and clinical characteristics associated with ITP in children.
  • To explore potential triggers for ITP in the pediatric population.

Main Methods:

  • Utilized the General Practice Research Database (GPRD) for patient data.
  • Identified 257 pediatric ITP cases between 1990 and 2005.
  • Calculated age- and sex-specific incidence rates per 100,000 person-years.

Main Results:

  • Overall pediatric ITP incidence was 4.2 per 100,000 person-years.
  • Boys aged 2-5 years showed significantly higher ITP incidence (9.7/100,000 PY) than girls (4.7/100,000 PY).
  • Teenagers (13-17 years) had lower incidence (2.4/100,000 PY) with similar rates in both sexes. Infection or immunization preceded diagnosis in 20.2% and 8.6% of cases, respectively. Two deaths occurred.

Conclusions:

  • ITP incidence in children varies by age and sex, indicating different disease burden patterns.
  • While rarely fatal, ITP is a significant pediatric condition.
  • The etiology of ITP remains largely unexplained in most pediatric cases.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.